Kerry Wentworth
CIK: 0001369453
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nuvation Bio Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 23, 2026NUVB
Nuvation Bio Inc.
Sale(S)Direct63K shares at avg. $6.02$379K - Jun 23, 2026NUVB
Nuvation Bio Inc.
Exercise(M)Direct63K shares at avg. $2.93$185K - Apr 17, 2026NUVB
Nuvation Bio Inc.
Exercise(M)Direct36.8K shares at avg. $2.93$108K - Apr 17, 2026NUVB
Nuvation Bio Inc.
Sale(S)Direct36.8K shares at avg. $5.01$184K - Apr 6, 2026NUVB
Nuvation Bio Inc.
Exercise(M)Direct100K shares at avg. $1.94$194K - Apr 6, 2026NUVB
Nuvation Bio Inc.
Exercise(M)Direct100K shares at avg. $1.87$187K - Apr 6, 2026NUVB
Nuvation Bio Inc.
Sale(S)Direct200K shares at avg. $4.52$904K - Feb 27, 2026NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
748.1K shares- - Jun 16, 2025NUVB
Nuvation Bio Inc.
Purchase(P)Direct24K shares at avg. $1.80$43K - Jun 16, 2025NUVB
Nuvation Bio Inc.
Purchase(P)Direct26K shares at avg. $1.79$47K - Feb 28, 2025NUVB
Nuvation Bio Inc.
Award(A)DirectStock Option (Right to Buy)
500K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | Sale(S) | 63,000 | $6.02 | $379,191 | Direct |
| Jun 23, 2026 | NUVB Nuvation Bio Inc. | Exercise(M) | 63,000 | $2.93 | $184,590 | Direct |
| Apr 17, 2026 | NUVB Nuvation Bio Inc. | Exercise(M) | 36,750 | $2.93 | $107,678 | Direct |
| Apr 17, 2026 | NUVB Nuvation Bio Inc. | Sale(S) | 36,750 | $5.01 | $184,279 | Direct |
| Apr 6, 2026 | NUVB Nuvation Bio Inc. | Exercise(M) | 100,000 | $1.94 | $194,000 | Direct |
| Apr 6, 2026 | NUVB Nuvation Bio Inc. | Exercise(M) | 100,000 | $1.87 | $187,000 | Direct |
| Apr 6, 2026 | NUVB Nuvation Bio Inc. | Sale(S) | 200,000 | $4.52 | $903,560 | Direct |
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | Award(A) Stock Option (Right to Buy) | 748,130 | - | - | Direct |
| Jun 16, 2025 | NUVB Nuvation Bio Inc. | Purchase(P) | 24,000 | $1.80 | $43,200 | Direct |
| Jun 16, 2025 | NUVB Nuvation Bio Inc. | Purchase(P) | 26,000 | $1.79 | $46,540 | Direct |
| Feb 28, 2025 | NUVB Nuvation Bio Inc. | Award(A) Stock Option (Right to Buy) | 500,000 | - | - | Direct |
1-11 of 11 transactions
About Wentworth Kerry
Wentworth Kerry (SEC CIK 0001369453) files insider reports with the SEC as CHIEF REGULATORY OFFICER of Nuvation Bio Inc. (NUVB).
Signal8 holds 6 ownership filings by Wentworth Kerry, all Form 4s, filed between Mar 4, 2025 and Jun 24, 2026. Those filings report 11 transactions, from Feb 28, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wentworth Kerry's filings is in NEW YORK, NY.
Recent filings by Wentworth Kerry
- Jun 23, 2026: Open-market sale of NUVB shares (Form 4, code S).
- Jun 23, 2026: Option exercise of NUVB shares (Form 4, code M).
- Apr 17, 2026: Option exercise of NUVB shares (Form 4, code M).
- Apr 17, 2026: Open-market sale of NUVB shares (Form 4, code S).
- Apr 6, 2026: Option exercises of NUVB shares (2 lines, Form 4, code M).
Other insiders filing for Nuvation Bio Inc. (NUVB)
- Hattersley Gary, CHIEF SCIENTIFIC OFFICER
- Sauvage Philippe, Chief Financial Officer
- Markel Stacy, CHIEF PEOPLE OFFICER
- Mashal Robert, Director
- VERNON W ANTHONY, Director
- FALBERG KATHRYN E, Director